Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 5, 2002, Pages 785-792

  Pihlajamäki, Marja ^a   Kaijalainen, Tarja ^a   Huovinen, Pentti ^a   Jalava, Jari ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BACTERIAL PROTEIN; CEFACLOR; CEFALOTIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; METHYLTRANSFERASE; MIKAMYCIN B; PENICILLIN G; PROTEIN L4; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBOSOME RNA; SPIRAMYCIN; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; COUNTER IMMUNOELECTROPHORESIS; DIAGNOSTIC KIT; DILUTION; FINLAND; GENE IDENTIFICATION; GENE MUTATION; HUMAN; LATEX AGGLUTINATION TEST; MICROBIAL SENSITIVITY TEST; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; PHENOTYPE; POLYMERASE CHAIN REACTION; SEROTYPING; STRAIN IDENTIFICATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; DRUG EFFECT; DRUG RESISTANCE; DRUG UTILIZATION; GENETICS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE; DRUG UTILIZATION; FINLAND; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0036001173     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf033     Document Type: Article

References (34)

1. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States
2. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
3. Erythromycin resistance by ribosome modification
4. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: A common resistance pattern mediated by an efflux system
5. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants
6. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae
7. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes
8. Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece
9. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage
10. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from eastern Europe and North America
11. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland
12. Erythromycin resistance genes in group A streptococci in Finland
13. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes
14. Detection of erythromycin-resistant determinants by PCR
15. Ribosomal mutations in Streptococcus pneumoniae clinical isolates
16. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
17. pC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain
18. Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990
19. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents
20. Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy
21. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy
22. Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Observatoire de Normandie du Pneumocoque
23. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France
24. Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life
25. Macrolide resistance in Belgian Streptococcus pneumoniae
26. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
27. Pneumococcal resistance in the UK
28. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998
29. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995
30. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
31. Macrolide resistance in Streptococcus pneumoniae in Hong Kong